The University of Manchester’s approach to cancer research spans the full spectrum of combating the disease.
One in two of us will be diagnosed with some form of cancer during our lifetime. Cancer may be one illness, but there are over 200 types – and a diagnosis affects whole families.
Breadth of our research
The University of Manchester’s medical research ranges from understanding the molecular and cellular basis of cancer to the development and testing of novel drugs and other therapeutic approaches. Through nursing, psychology and policy work, solutions to the physical, emotional and economic impacts of cancer are being researched and put into practice across the University.
Led by world-renowned scientists such as Professor Sir Salvador Moncada and Professor Richard Marais, cancer research at the University has the academic strength to match the weight of our partnerships and the benefits of our location.
Reach and impact
Our links with NHS organisations and cancer charities – as well as the support of the local population – make for an unrivalled beacon of research, where outstanding clinical work is leading to innovative techniques and personalised treatments.
Through the Manchester Cancer Research Centre we work with Cancer Research UK and The Christie NHS Foundation Trust to turn research findings in the laboratory into better, more effective, treatments for cancer patients. The Centre’s new building will house 150 researchers and world-class facilities for imaging and sample analysis.
Our trials led to anastrozole replacing tamoxifen as the major endocrine therapy for breast cancer, a development that has benefited 1.5 million women globally. Our partnerships with companies such as AstraZeneca and GlaxoSmithKline bring new drugs to the market.
And we’re reaching out to where help is needed most – such as in Uganda, where our academics and medics are helping to roll out a national programme of cervical cancer screening.
Cancer is a disease that affects so many, in different, often devastating, ways. At The University of Manchester we want to loosen cancer’s grip and improve the lives of those it affects.
Cancer: Research breakthroughs
Helping more women to survive the most common form of cancer.
Breakthrough drug trials are helping more children survive leukaemia than ever before.
New test set to transform breast cancer prevention
Researchers at the University and Manchester University NHS Foundation Trust have developed a new genetic test for breast cancer.
Lung cancer treatment could be having negative health effect on hearts
Radiotherapy treatment for lung cancer could have a negative effect on the health of your heart, new research has found.
Step forward taken in understanding of oesophageal cancer
By looking for molecular signatures within the human genome, scientists at Manchester have identified some key factors that establish oesophageal cancer cells.
Specialists make breakthrough in the treatment of anal cancer
Specialists at The Christie and the University have made a breakthrough which could improve detection and treatment of anal cancer, with wider implications for other cancers.
Advanced radiotherapy improves lung cancer survival rates
A ten-year University of Manchester and Christie NHS Foundation Trust study has achieved the best survival rates and lowest toxicity ever reported.
World leading clinician-scientist to head Manchester cancer research
Renowned prostate cancer expert, Professor Rob Bristow, has been appointed as Director of the Manchester Cancer Research Centre.
Cancer research at Manchester
Find out more about cancer research at the Faculty of Biology, Medicine and Health.
Visit the Faculty of Biology, Medicine and Health website
Manchester Cancer Research Centre
The MCRC was formed in 2006 by the University, CRUK and The Christie NHS Foundation Trust.
Visit the MCRC website
Cancer Research UK Manchester Institute
A leading cancer research institute within the University, core funded by Cancer Research UK.
Visit the CRUK Manchester Institute website